Introduction: historical perspective and development of amoxicillin/clavulanate.
about
Staphylococcal phenotypes induced by naturally occurring and synthetic membrane-interactive polyphenolic β-lactam resistance modifiersEfficacy of ampicillin against methicillin-resistant Staphylococcus aureus restored through synergy with branched poly(ethylenimine)Overcoming resistance to β-lactam antibiotics.Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.Wall teichoic acids of gram-positive bacteria.Navigating tuberculosis drug discovery with target-based screening.Lysine-Targeting Covalent Inhibitors.5-Alkyloxytryptamines are membrane-targeting, broad-spectrum antibiotics.Tetracyclic indolines as a novel class of β-lactam-selective resistance-modifying agent for MRSA.Saliva, supragingival biofilm and root canals can harbor gene associated with resistance to lactamic agents.Role of oral antibiotics for prophylaxis against surgical site infections after elective colorectal surgery.Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics.Tackling the Antibiotic Resistance Caused by Class A -Lactamases through the Use of -Lactamase Inhibitory Protein
P2860
Q28541941-93DCF9F7-F5A4-4100-BC0E-E0388FCB4893Q28821040-7CECA685-C007-406D-9F4F-58C297FC13A5Q34636678-FEE672CE-1FD8-4396-8653-E95B7F9BFC0DQ36087058-2AF948EF-12CB-4918-8289-5507C7E528E5Q37442758-C59F274F-12DE-430A-A0BD-3BD2900355AFQ38014956-4591E932-DE12-4385-97AC-950CB451E60BQ38635726-5104F12E-AAC7-4AEF-9D30-741D81D5A12EQ40495313-FB13156A-6BAD-4C9D-843E-EDC8F7E45454Q40530965-3946D455-02F4-4578-8129-80246778FAF9Q41410259-AAEB415C-D804-4488-AB23-A62D9C30CB67Q49715878-18B92617-DCE6-48FB-A9BB-74B8E18E8930Q52655525-4D09C085-48F8-4E6D-8F99-99E21F23E817Q55398522-A0439BDE-F039-448C-806F-777C00A9A181Q57174160-17EFDB57-C7E1-4B10-B336-8AC59162CB32
P2860
Introduction: historical perspective and development of amoxicillin/clavulanate.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Introduction: historical perspective and development of amoxicillin/clavulanate.
@ast
Introduction: historical perspective and development of amoxicillin/clavulanate.
@en
Introduction: historical perspective and development of amoxicillin/clavulanate.
@nl
type
label
Introduction: historical perspective and development of amoxicillin/clavulanate.
@ast
Introduction: historical perspective and development of amoxicillin/clavulanate.
@en
Introduction: historical perspective and development of amoxicillin/clavulanate.
@nl
prefLabel
Introduction: historical perspective and development of amoxicillin/clavulanate.
@ast
Introduction: historical perspective and development of amoxicillin/clavulanate.
@en
Introduction: historical perspective and development of amoxicillin/clavulanate.
@nl
P1476
Introduction: historical perspective and development of amoxicillin/clavulanate.
@en
P2093
Alasdair M Geddes
George N Rolinson
P304
P356
10.1016/J.IJANTIMICAG.2007.07.015
P478
30 Suppl 2
P577
2007-09-27T00:00:00Z